Tenet Healthcare Corporation

NYSE:THC Rapport sur les actions

Capitalisation boursière : US$14.6b

Tenet Healthcare Croissance future

Future contrôle des critères 0/6

Les bénéfices de Tenet Healthcare devraient diminuer de 39.2% par an tandis que son chiffre d'affaires annuel devrait croître de 3.5% par an. Le BPA devrait croître de diminuer de 41% par an. Le rendement des capitaux propres devrait être 11.4% dans 3 ans.

Informations clés

-39.2%

Taux de croissance des bénéfices

-41.0%

Taux de croissance du BPA

Healthcare croissance des bénéfices20.8%
Taux de croissance des recettes3.5%
Rendement futur des capitaux propres11.4%
Couverture par les analystes

Good

Dernière mise à jour15 Nov 2024

Mises à jour récentes de la croissance future

Recent updates

Here's Why Tenet Healthcare (NYSE:THC) Has A Meaningful Debt Burden

Nov 17
Here's Why Tenet Healthcare (NYSE:THC) Has A Meaningful Debt Burden

Tenet Healthcare: Targeting More Stable Demand In High-Acuity Services

Nov 04

With EPS Growth And More, Tenet Healthcare (NYSE:THC) Makes An Interesting Case

Oct 30
With EPS Growth And More, Tenet Healthcare (NYSE:THC) Makes An Interesting Case

Tenet Healthcare: Becoming A Very Healthy Business

Sep 09

Earnings Working Against Tenet Healthcare Corporation's (NYSE:THC) Share Price

Sep 06
Earnings Working Against Tenet Healthcare Corporation's (NYSE:THC) Share Price

Tenet Healthcare: Strong EPS Growth, But Shares Near FV (Rating Downgrade)

Aug 29

Here's Why Tenet Healthcare (NYSE:THC) Has A Meaningful Debt Burden

Aug 13
Here's Why Tenet Healthcare (NYSE:THC) Has A Meaningful Debt Burden

An Intrinsic Calculation For Tenet Healthcare Corporation (NYSE:THC) Suggests It's 42% Undervalued

Jul 11
An Intrinsic Calculation For Tenet Healthcare Corporation (NYSE:THC) Suggests It's 42% Undervalued

Tenet Healthcare: Asset Sales, Current Multiples Support Re-Rating (Rating Upgrade)

Jun 17

With EPS Growth And More, Tenet Healthcare (NYSE:THC) Makes An Interesting Case

May 21
With EPS Growth And More, Tenet Healthcare (NYSE:THC) Makes An Interesting Case

Tenet Healthcare Corporation's (NYSE:THC) Shareholders Might Be Looking For Exit

Apr 30
Tenet Healthcare Corporation's (NYSE:THC) Shareholders Might Be Looking For Exit

Does Tenet Healthcare (NYSE:THC) Have A Healthy Balance Sheet?

Mar 18
Does Tenet Healthcare (NYSE:THC) Have A Healthy Balance Sheet?

Tenet Healthcare: Shrinking To Grow

Feb 04

Tenet Healthcare Corporation (NYSE:THC) Might Not Be As Mispriced As It Looks

Dec 18
Tenet Healthcare Corporation (NYSE:THC) Might Not Be As Mispriced As It Looks

We Think Tenet Healthcare (NYSE:THC) Is Taking Some Risk With Its Debt

Nov 15
We Think Tenet Healthcare (NYSE:THC) Is Taking Some Risk With Its Debt

Tenet Healthcare: A Compelling Opportunity Despite Lofty Debt

Oct 13

Is Tenet Healthcare (NYSE:THC) Using Too Much Debt?

Aug 02
Is Tenet Healthcare (NYSE:THC) Using Too Much Debt?

Tenet Healthcare: Muted Earnings Outlook Doesn't Inspire Confidence For Now

Jul 28

Does This Valuation Of Tenet Healthcare Corporation (NYSE:THC) Imply Investors Are Overpaying?

Apr 13
Does This Valuation Of Tenet Healthcare Corporation (NYSE:THC) Imply Investors Are Overpaying?

USPI and Providence extend hands to aid ambulatory surgical services

Feb 09

Prévisions de croissance des bénéfices et des revenus

NYSE:THC - Estimations futures des analystes et données financières antérieures (USD Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
12/31/202622,4711,1782,1322,75015
12/31/202521,3931,0692,1042,56417
12/31/202420,7933,1501,9802,43117
9/30/202420,9723,1262,3933,202N/A
6/30/202420,9162,7551,8912,660N/A
3/31/202420,8952,6191,7552,511N/A
12/31/202320,5486111,6232,374N/A
9/30/202320,1594691,1381,971N/A
6/30/202319,8944999611,783N/A
3/31/202319,4534144621,304N/A
12/31/202219,1744103211,083N/A
9/30/202219,0405582431,019N/A
6/30/202219,1338754141,136N/A
3/31/202219,4499575701,262N/A
12/31/202119,4859159101,568N/A
9/30/202119,5441,0791,1371,657N/A
6/30/202119,2074341,3231,818N/A
3/31/202117,9014023,3333,812N/A
12/31/202017,6403992,8673,407N/A
9/30/202017,531-182,9293,481N/A
6/30/202017,542-482,6853,307N/A
3/31/202018,454-1126921,352N/A
12/31/201918,479-2265631,233N/A
9/30/201918,292-228258963N/A
6/30/201918,213-10197882N/A
3/31/201918,159-10280946N/A
12/31/201818,3131014321,049N/A
9/30/201818,672-1176711,290N/A
6/30/201818,769-474N/A1,260N/A
3/31/201819,065-554N/A1,127N/A
12/31/201719,179-704N/A1,200N/A
9/30/201719,061-553N/A416N/A
6/30/201719,324-196N/A377N/A
3/31/201719,390-184N/A597N/A
12/31/201619,621-187N/A558N/A
9/30/201619,787-208N/A1,042N/A
6/30/201619,630-227N/A1,255N/A
3/31/201619,254-243N/A1,230N/A
12/31/201518,634-142N/A1,026N/A
9/30/201518,07319N/A1,054N/A
6/30/201517,55657N/A793N/A
3/31/201517,101107N/A649N/A
12/31/201416,60334N/A687N/A
9/30/201416,023-44N/A723N/A
6/30/201414,256-21N/A708N/A
3/31/201412,641-64N/A602N/A
12/31/201311,087-123N/A589N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: Les bénéfices de THC devraient diminuer au cours des 3 prochaines années ( -39.2% par an).

Bénéfices vs marché: Les bénéfices de THC devraient diminuer au cours des 3 prochaines années ( -39.2% par an).

Croissance élevée des bénéfices: Les bénéfices de THC devraient baisser au cours des trois prochaines années.

Chiffre d'affaires vs marché: Le chiffre d'affaires de THC ( 3.5% par an) devrait croître plus lentement que le marché de US ( 9% par an).

Croissance élevée des revenus: Le chiffre d'affaires de THC ( 3.5% par an) devrait croître plus lentement que 20% par an.


Prévisions de croissance du bénéfice par action


Rendement futur des capitaux propres

ROE futur: Le retour sur capitaux propres de THC devrait être faible dans 3 ans ( 11.4 %).


Découvrir les entreprises en croissance